These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28581638)

  • 21. Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) results.
    López-Gatell H; García-García L; Echániz-Avilés G; Cruz-Hervert P; Olamendi-Portugal M; Castañeda-Desales D; Sanchez-Alemán MÁ; Romero-Martínez M; DeAntonio R; Cervantes-Apolinar MY; Cortes-Alcalá R; Alpuche-Aranda C
    Hum Vaccin Immunother; 2019; 15(2):433-439. PubMed ID: 30380981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High level of exposure to hepatitis B virus infection in a vulnerable population of a low endemic area: A challenge for vaccination coverage.
    Weis-Torres SMDS; Fitts SMF; Cardoso WM; Higa Junior MG; Lima LA; Bandeira LM; Castro VOL; Carneiro FA; Iglecias LMM; Cesar GA; Tanaka TSO; Puga MAM; Rezende GR; Croda J; Lago BV; Motta-Castro ARC
    Int J Infect Dis; 2020 Jan; 90():46-52. PubMed ID: 31589921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
    Liu Y; Ma C; Jia H; Xu E; Zhou Y; Zhang Z; Lu L; Rodewald L; Hao L
    Vaccine; 2018 Apr; 36(17):2307-2313. PubMed ID: 29567035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distribution of hepatitis B virus exposure and infection in a population-based sample of U.S. Hispanic adults.
    Jung M; Kuniholm MH; Ho GY; Cotler S; Strickler HD; Thyagarajan B; Youngblood M; Kaplan RC; Del Amo J
    Hepatology; 2016 Feb; 63(2):445-52. PubMed ID: 26523403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.
    Spradling PR; Richardson JT; Buchacz K; Moorman AC; Brooks JT;
    J Viral Hepat; 2010 Dec; 17(12):879-86. PubMed ID: 20158604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
    Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China.
    Zhang H; Li Q; Sun J; Wang C; Gu Q; Feng X; Du B; Wang W; Shi X; Zhang S; Li W; Jiang Y; Feng J; He S; Niu J
    Int J Med Sci; 2011; 8(4):321-31. PubMed ID: 21611114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B virus infection and uptake of hepatitis B vaccine among healthcare workers, Makueni County, Kenya 2017.
    Kisangau EN; Awour A; Juma B; Odhiambo D; Muasya T; Kiio SN; Too R; Lowther SA
    J Public Health (Oxf); 2019 Dec; 41(4):765-771. PubMed ID: 30351408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus infection and vaccine-induced immunity in Madrid (Spain).
    Pedraza-Flechas AM; García-Comas L; Ordobás-Gavín M; Sanz-Moreno JC; Ramos-Blázquez B; Astray-Mochales J; Moreno-Guillén S
    Gac Sanit; 2014; 28(6):492-5. PubMed ID: 25042394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18-49 Years With Risk Factors for Hepatitis B Virus Infection-United States, 2003-2014.
    King H; Xing J; Dean HD; Holtzman D
    Clin Infect Dis; 2020 Apr; 70(9):1907-1915. PubMed ID: 31228240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection.
    Grzegorzewska AE; Wobszal PM; Sowińska A; Mostowska A; Jagodziński PP
    Mol Biol Rep; 2013 Dec; 40(12):6899-911. PubMed ID: 24158609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy.
    Lin CC; Yang CY; Shih CT; Chen BH; Huang YL
    Am J Infect Control; 2011 Jun; 39(5):408-414. PubMed ID: 21255876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study.
    Hiva S; Negar K; Mohammad-Reza P; Gholam-Reza G; Mohsen A; Ali-Asghar NG; Mohammed-Jafar S
    BMC Public Health; 2020 Jun; 20(1):920. PubMed ID: 32532228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of hepatitis B-antibody loss and a case report of
    Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
    World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL; Shu ZJ; Zhou LX; Zhao YR
    Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B Knowledge, Testing, and Vaccination History among Undergraduate Public Health Students in Ghana.
    Osei E; Niyilapah J; Kofi Amenuvegbe G
    Biomed Res Int; 2019; 2019():7645106. PubMed ID: 31485444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.